Cancer scientists in Britain are launching what they call the world’s first “Darwinian” drug development program in a bid to get ahead of cancer’s ability to become resistant to even the newest treatments and recur in many patients.
Unlock the Full Story — Join Thousands of Informed Kenyans Today
- Unlimited access to all premium content
- Uninterrupted ad-free browsing experience
- Mobile-optimized reading experience
- Weekly Newsletters
- MPesa, Airtel Money and Cards accepted